192 related articles for article (PubMed ID: 38434965)
1. Pan-Cancer Analysis of PGAM1 and Its Experimental Validation in Uveal Melanoma Progression.
Niu W; Yang Y; Teng Y; Zhang N; Li X; Qin Y
J Cancer; 2024; 15(7):2074-2094. PubMed ID: 38434965
[TBL] [Abstract][Full Text] [Related]
2. Prognostic values of Annexins and validation of the influence on cell proliferation, migration, and invasion in uveal melanoma.
Zhao A; Wang Z; Wang Y; Chen X
Am J Transl Res; 2023; 15(5):3131-3151. PubMed ID: 37303667
[TBL] [Abstract][Full Text] [Related]
3. Phosphoglycerate mutase 1 knockdown inhibits prostate cancer cell growth, migration, and invasion.
Wen YA; Zhou BW; Lv DJ; Shu FP; Song XL; Huang B; Wang C; Zhao SC
Asian J Androl; 2018; 20(2):178-183. PubMed ID: 29271400
[TBL] [Abstract][Full Text] [Related]
4. RASD2 promotes the development and metastasis of uveal melanoma via enhancing glycolysis.
Xie M; Xin C
Biochem Biophys Res Commun; 2022 Jun; 610():92-98. PubMed ID: 35461072
[TBL] [Abstract][Full Text] [Related]
5. Phosphoglycerate Mutase 1 (PGAM1) Promotes Pancreatic Ductal Adenocarcinoma (PDAC) Metastasis by Acting as a Novel Downstream Target of the PI3K/Akt/mTOR Pathway.
Liu X; Tan X; Liu P; Wu Y; Qian S; Zhang X
Oncol Res; 2018 Aug; 26(7):1123-1131. PubMed ID: 29386088
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of nonerythrocytic spectrin Beta 1 (SPTBN1) in human kidney renal clear cell carcinoma and uveal melanoma: a study based on Pan-Cancer Analysis.
Tang W; Shao Q; He Z; Zhang X; Li X; Wu R
BMC Cancer; 2023 Apr; 23(1):303. PubMed ID: 37013511
[TBL] [Abstract][Full Text] [Related]
7. Identification of a novel immune-related gene signature for prognosis and the tumor microenvironment in patients with uveal melanoma combining single-cell and bulk sequencing data.
Wang W; Zhao H; Wang S
Front Immunol; 2023; 14():1099071. PubMed ID: 36793711
[TBL] [Abstract][Full Text] [Related]
8. Phosphoglycerate mutase 1 that is essential for glycolysis may act as a novel metabolic target for predicating poor prognosis for patients with gastric cancer.
Wei C; Xie J; Yuan X; Luo Y; Xiao Y; Liao W; Jiang Z
J Clin Lab Anal; 2022 Nov; 36(11):e24718. PubMed ID: 36181311
[TBL] [Abstract][Full Text] [Related]
9. BAG2 Is a Novel Prognostic Biomarker and Promising Immunotherapy Target in Uveal Melanoma.
Li C; Shi H
Crit Rev Eukaryot Gene Expr; 2023; 33(6):55-71. PubMed ID: 37522545
[TBL] [Abstract][Full Text] [Related]
10. Phosphoglycerate mutase 1 promotes breast cancer progression through inducing immunosuppressive M2 macrophages.
Zhang D; Wang M; Ma S; Liu M; Yu W; Zhang X; Liu T; Liu S; Ren X; Sun Q
Cancer Gene Ther; 2024 May; ():. PubMed ID: 38750301
[TBL] [Abstract][Full Text] [Related]
11. Dysregulation of B7 family and its association with tumor microenvironment in uveal melanoma.
Chen Y; Zheng A; Zhang Y; Xiao M; Zhao Y; Wu X; Li M; Du F; Chen Y; Chen M; Li W; Li X; Sun Y; Gu L; Xiao Z; Shen J
Front Immunol; 2022; 13():1026076. PubMed ID: 36311731
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-592 serves as a novel tumor suppressor in Uveal melanoma: bioinformatics analysis and in vitro cell function verification.
Lei P; Xue L; Wu Y; Zhong J
Bioengineered; 2022; 13(7-12):15033-15044. PubMed ID: 37105900
[TBL] [Abstract][Full Text] [Related]
13. Phosphoglycerate mutase 1 promotes cancer cell migration independent of its metabolic activity.
Zhang D; Jin N; Sun W; Li X; Liu B; Xie Z; Qu J; Xu J; Yang X; Su Y; Tang S; Han H; Chen D; Ding J; Tan M; Huang M; Geng M
Oncogene; 2017 May; 36(20):2900-2909. PubMed ID: 27991922
[TBL] [Abstract][Full Text] [Related]
14. PGAM1, regulated by miR-3614-5p, functions as an oncogene by activating transforming growth factor-β (TGF-β) signaling in the progression of non-small cell lung carcinoma.
Li F; Yang H; Kong T; Chen S; Li P; Chen L; Cheng J; Cui G; Zhang G
Cell Death Dis; 2020 Aug; 11(8):710. PubMed ID: 32855383
[TBL] [Abstract][Full Text] [Related]
15. PGAM1 suppression remodels the tumor microenvironment in triple-negative breast cancer and synergizes with anti-PD-1 immunotherapy.
Zhang D; Wang M; Wang W; Ma S; Yu W; Ren X; Sun Q
J Leukoc Biol; 2024 Mar; ():. PubMed ID: 38478709
[TBL] [Abstract][Full Text] [Related]
16. A Novel Glycolysis-Related Signature for Predicting the Prognosis and Immune Infiltration of Uveal Melanoma.
Guo X; Yu X; Zhang Y; Luo H; Huang R; Zeng Y; Duan C; Chen C
Ophthalmic Res; 2023; 66(1):692-705. PubMed ID: 36858025
[TBL] [Abstract][Full Text] [Related]
17. Phosphoglycerate Mutase 1 Predicts the Poor Prognosis of Oral Squamous Cell Carcinoma and is Associated with Cell Migration.
Zhang D; Wu H; Zhang X; Ding X; Huang M; Geng M; Li H; Xie Z
J Cancer; 2017; 8(11):1943-1951. PubMed ID: 28819393
[TBL] [Abstract][Full Text] [Related]
18. Phosphoglycerate Mutase 1: Its Glycolytic and Non-Glycolytic Roles in Tumor Malignant Behaviors and Potential Therapeutic Significance.
Li N; Liu X
Onco Targets Ther; 2020; 13():1787-1795. PubMed ID: 32161473
[TBL] [Abstract][Full Text] [Related]
19. TAP1, a potential immune-related prognosis biomarker with functional significance in uveal melanoma.
Zhu R; Chen YT; Wang BW; You YY; Wang XH; Xie HT; Jiang FG; Zhang MC
BMC Cancer; 2023 Feb; 23(1):146. PubMed ID: 36774490
[TBL] [Abstract][Full Text] [Related]
20. The diagnostic value and functional roles of phosphoglycerate mutase 1 in glioma.
Xu Z; Gong J; Wang C; Wang Y; Song Y; Xu W; Liu Z; Liu Y
Oncol Rep; 2016 Oct; 36(4):2236-44. PubMed ID: 27572934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
